The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 21, Issue 5, 2015, Pages 468-473

  Fountas, Athanasios ^a   Andrikoula, Maria ^a   Giotaki, Zoi ^a   Limniati, Christina ^a   Tsakiridou, Efthymia ^a   Tigas, Stelios ^a   Tsatsoulis, Agathocles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; DENOSUMAB; PARATHYROID HORMONE;

AGED; BLOOD; CASE REPORT; COMPLICATION; DRUG RESISTANCE; HUMAN; HYPERCALCEMIA; MALE; MIDDLE AGED; PARATHYROID TUMOR;

AGED; CALCIMIMETIC AGENTS; DENOSUMAB; DIPHOSPHONATES; DRUG RESISTANCE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS;

EID: 84982094819     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP14410.OR     Document Type: Article

References (0)